Central diabetes insipidus is due to a deficiency of antidiuretic hormone (ADH) and therefore its defining characteristic is polyuria. Nephrogenic diabetes insipidus is caused by a failure of the kidney to recognize or respond ADH and therefore also leads to polyuria. Both conditions stem from an inability of the kidneys to reabsorb water. The consequences of polyuria are polydipsia and nocturia-other important characteristics of central diabetes insipidus. A serious complication is a dehydration if the patient is unable to drink enough water to replace the fluids lost.

The origins of central diabetes insipidus (central DI) are varied. Only about ten percent of central DI cases have a genetic background [1]. The pattern of inheritance may be autosomal dominant [2], which is due to the accumulation of hormone precursors toxic to neurons. Autosomal recessive forms are also observed, owing to genetic changes in the arginine vasopressin-neurophysin II gene.

Most of the central DI cases are due to non-genetic effects, such as brain injury, brains tumors, or brain surgery. Thus, a history of such events will suggest a neurogenic, or central origin of the condition as opposed to nephrogenic disease. Idiopathic cases are also fairly common. The disease may be caused by autoimmune and inflammatory conditions. Among tumors associated with central DI is craniopharyngioma, the most common pediatric intracranial tumor. Postoperative central DI may occur after various surgeries; almost 20% of patients undergoing transsphenoidal pituitary adenoma surgery developed central DI, which, in most cases, resolved spontaneously in a little over a week [3]. Of patients with serious head injuries, about 15% developed central DI. The most important risk factors were severe head trauma and penetrating trauma [4].

Central DI may be transient, permanent, or triphasic. The triphasic condition starts with a few days of polyuria, followed by amelioration of the symptoms for another few days (owing to release of stored antidiuretic hormone), and ends with permanent central DI.

The symptoms in infants are less specific than in adults and include irritability, crying, weight loss, and growth delays. Apart from nephrogenic DI, central DI needs to be differentiated from psychogenic polydipsia.

Laboratory studies should include determination of serum electrolyte and glucose, urinary osmolality with simultaneous plasma osmolality values, and the specific gravity of the urine. A large volume of dilute urine, the osmolality (<300 mOsm/kg) of which is lower than that of plasma, is a strong indication for diabetes insipidus (DI) [5]. A reliable test for the detection of DI is the water deprivation test which needs to be performed under supervision to avoid dangerous dehydration. During the test, healthy people will pass urine with an osmolality significantly higher than the plasma osmolality; urine osmolality does not change much after antidiuretic hormone administration. In patients with DI, the urinary osmolality remains low after water deprivation. It will be raised by antidiuretic hormone administration in central DI, but not in nephrogenic DI [6]. Measurement of antidiuretic hormone levels during the water deprivation test increases the accuracy of diagnosis [7].

Determination of levels of other pituitary hormones is recommended in cases of traumatic head injury [8]. Magnetic resonance imaging (MRI) may aid in the diagnosis of central DI because the hyperintense signal seen in T1-weighted images of a healthy posterior pituitary gland is lost in patients suffering from central DI.

Treatment for Central Diabetes Insipidus focuses on managing symptoms and addressing the underlying cause. Desmopressin, a synthetic form of ADH, is commonly prescribed to reduce urine output and control thirst. It can be administered as a nasal spray, oral tablet, or injection. In cases where CDI is caused by a tumor or injury, treating the underlying condition may improve symptoms. Patients are also advised to maintain adequate hydration and monitor their fluid intake.

The prognosis for individuals with Central Diabetes Insipidus varies depending on the underlying cause. With appropriate treatment, most patients can manage their symptoms effectively and lead normal lives. However, if left untreated, CDI can lead to severe dehydration and electrolyte imbalances, which can be life-threatening. Regular follow-up with a healthcare provider is essential to monitor the condition and adjust treatment as needed.

Central Diabetes Insipidus can result from various causes, including damage to the hypothalamus or pituitary gland. This damage may be due to head injuries, brain tumors, infections, or surgical procedures. In some cases, CDI is idiopathic, meaning the cause is unknown. Genetic factors may also play a role, as some forms of CDI are inherited.

Central Diabetes Insipidus is a rare disorder, with an estimated prevalence of 1 in 25,000 individuals. It can occur at any age but is most commonly diagnosed in adults. There is no significant gender predilection. The rarity of the condition often leads to delays in diagnosis, as its symptoms can mimic those of more common disorders.

The pathophysiology of Central Diabetes Insipidus involves a deficiency of vasopressin production or release. Vasopressin is synthesized in the hypothalamus and stored in the posterior pituitary gland. It acts on the kidneys to promote water reabsorption, reducing urine output. In CDI, the lack of vasopressin leads to the kidneys' inability to concentrate urine, resulting in excessive water loss and increased thirst.

Preventing Central Diabetes Insipidus involves addressing risk factors and underlying conditions that may lead to the disorder. For instance, managing head injuries promptly and effectively can reduce the risk of developing CDI. Regular monitoring and treatment of conditions affecting the hypothalamus or pituitary gland can also help prevent the onset of CDI.

Central Diabetes Insipidus is a rare condition characterized by excessive urination and thirst due to a deficiency of the hormone vasopressin. It can result from various causes, including brain injuries and tumors. Diagnosis involves a combination of clinical evaluation, laboratory tests, and imaging studies. Treatment typically includes desmopressin and managing the underlying cause. With proper management, individuals with CDI can lead normal lives.

If you have been diagnosed with Central Diabetes Insipidus, it's important to understand your condition and how to manage it. CDI is caused by a lack of a hormone that helps your body conserve water. This leads to frequent urination and thirst. Treatment usually involves taking a medication called desmopressin, which helps control these symptoms. Staying hydrated and following your doctor's advice are key to managing CDI effectively. Regular check-ups will help ensure your treatment is working and adjust it if necessary.

1. Fujiwara TM, Bichet DG. Molecular biology of hereditary diabetes insipidus. J Am Soc Nephrol. 2005;16(10):2836-2346.
2. Hedrich CM1, Zachurzok-Buczynska A, Gawlik A, et al. Autosomal dominant neurohypophyseal diabetes insipidus in two families. Molecular analysis of the vasopressin-neurophysin II gene and functional studies of three missense mutations. Horm Res. 2009;71(2):111-119.
3. Kristof RA, Rother M, Neuloh G, Klingmüller D. Incidence, clinical manifestations, and course of water and electrolyte metabolism disturbances following transsphenoidal pituitary adenoma surgery: a prospective observational study. J Neurosurg. 2009;111(3):555-562.
4. Hadjizacharia P, Beale EO, Inaba K, Chan LS, Demetriades D. Acute diabetes insipidus in severe head injury: a prospective study. J Am Coll Surg. 2008;207(4):477-484.
5. Seckl J, Dunger D. Postoperative diabetes insipidus. BMJ. 1989;298(6665):2-3.
6. Di Iorgi N, Napoli F, Allegri AE, et al. Diabetes insipidus--diagnosis and management. Horm Res Paediatr. 2012;77(2):69-84.
7. Zerbe RL, Robertson GL. A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria. N Engl J Med. 1981;24;305(26):1539-1546.
8. Krahulik D, Zapletalova J, Frysak Z, Vaverka M. Dysfunction of hypothalamic-hypophysial axis after traumatic brain injury in adults. J Neurosurg. 2010;113(3):581-584.